Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Characterization of Early Markers of Choroidal Neovascularization in Fellow Eyes of Patients With AMD and CNV in One Eye. (CNV-Markers)
Authors not listed
Association for Innovation and Biomedical Research on Light and Image · 2005
Abstract
To this study and identify the sequence of alterations occurring in the chorioretinal interface during progression of AMD from "dry" AMD to sight-threatening chorioretinal neovascularization (CNV).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2005). Characterization of Early Markers of Choroidal Neovascularization in Fellow Eyes of Patients With AMD and CNV in One Eye. (CNV-Markers). <em>Association for Innovation and Biomedical Research on Light and Image</em>. https://clinicaltrials.gov/study/NCT00801541
Vancouver
Anonymous. Characterization of Early Markers of Choroidal Neovascularization in Fellow Eyes of Patients With AMD and CNV in One Eye. (CNV-Markers). Association for Innovation and Biomedical Research on Light and Image. 2005.
BibTeX
@misc{anon2005Charac,
title = {Characterization of Early Markers of Choroidal Neovascularization in Fellow Eyes of Patients With AMD and CNV in One Eye. (CNV-Markers)},
author = {Anonymous},
journal = {Association for Innovation and Biomedical Research on Light and Image},
year = {2005},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pfizer 2008
Open access · US-GOV
A Two-Year Exploratory, Observational, Non-Interventional Multicenter Study To Identify Early Markers Of Choroidal Neovascularization In Fellow Eyes Of Patients With Neovascular AMD In One Eye
Notal Vision Ltd. 2009
Open access · US-GOV
Comparison Between Home Macular Perimeter (FORESEE HOME) and OCT Visual Field Defects in Patients With CNV
Archives of Ophthalmology 2009
Citation only
Forecasting Age-Related Macular Degeneration Through the Year 2050
Notal Vision Ltd. 2009
Open access · US-GOV
Correlation Between Visual Field Defects on Home Macular Perimeter (FORESEE HOME) and on OCT in Eyes of Patients With CNV Before and After Treatment
Novartis 2005
Open access · US-GOV
Open-label Multicenter, Phase I/II Study Assessing the Safety and Efficacy of Ranibizumab (RFB002) in Japanese Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Iconic Therapeutics, Inc. 2015
Open access · US-GOV